Claes Glassell

Independence: Independent of the Company and management and of major shareholders.

Direct or related person ownership: 10,000 class B shares.

Committee work: Member of the People & Renumeration Committee.

Other current significant assignments: Board Director of Cambrec Corp. Senior advisor to Permira.

Social media: LinkedIn

Claes Glassell was elected a Director of the Kinnevik Board in 2024. Between 1999-2003, Claes was Chief Operating Officer and President of Cambrex Corp. He then served as Chief Executive Officer of Cerus Corp. from 2004-2011 and CMC Biologics from 2011-2015. Claes was Chair of the Board of LSNE from 2017-2021 and Chair of the Board of Quotient Sciences from 2019-2022. Additionally, he has previously held senior positions and served on the boards of several public and private companies and industry bodies, including Vitrolife AB, Cellartis AB, Nobel Chemicals, Berol Nobel, the Swedish Chamber of Commerce in New York, and the Swedish Chemical Industry Association. Claes holds a master's degree in Chemical Engineering from Chalmers University of Technology.